Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) Quality Rank

View and export this data going back to 2023. Start your Free Trial

What is Bellevue Life Sciences Acquisition Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

Bellevue Life Sciences Acquisition Quality Rank Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bellevue Life Sciences Acquisition (Bellevue Life Sciences Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Bellevue Life Sciences Acquisition Corp (NAS:BLAC) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

10900 NE 4th Street, Suite 2300, Bellevue, WA, USA, 98004

Website

Bellevue Life Sciences Acquisition Corp is a blank check company.

Executives

David Jin Yoo	officer: Chief Financial Officer	(135-270) 7TH FLOOR, SOFTFORUM B/D., 545-7 DOGOKDONG, GANGNAM, SEOUL M5 135-170
Kuk Hyoun Hwang	director, 10 percent owner, officer: Chief Executive Officer	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Bellevue Global Life Science Investors Llc	10 percent owner	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Steven Reed	other: Director Nominee	2843-122 PL. N.E., BELLEVUE WA 98005
In Chul Chung	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Hosun Euh	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jin Whan Park	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jun Chul Whang	director	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Rad Roberts	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004